With further prospective validation, it may become apparent that fewer biomarkers together can produce acceptable accuracy for active LN identification (e.g. AGP and ceruloplasmin) due to the level of correlation seen between biomarkers (especially for Cohort 2). The gene discussed is ATP5MK; the disease is lobular neoplasia.